ndothelial cells have an important role in the regulation of vascular function. Injuries to endothelial cells have been argued to be the initiating event in atherogenesis 1 as well as in the development of hypertensive arterial changes. 2 It has also been reported that endothelial damage is implicated in the pathogenesis of ischemia-reperfusion injury. 34 A growing body of evidence has recently suggested that oxygen-derived free radicals are a potential source of the deleterious effects on the vascular endothelium. 5 - 6 Endothelial cells located on the luminal surface of the vascular wall are vulnerable to attack by free radicals, leading to disruption of cell functions and even death. 7 - 9 Free radicals from oxidized lipids, drugs, and chemicals in the blood contribute to the initial endothelial damage, which can progress and develop into chronic progressive vascular injury. Activation of macrophages or their monocyte precursors after initial endothelial injury releases oxygen radicals that could injure neighboring cells and lead to further damage. Moreover, both endothelial cells and arterial smooth muscle cells have been shown in vitro to actively oxidize low-density lipoprotein, which could serve as a potential source of oxidized lipids. 10 - 11 It was also found that the partial pressure of oxygen is high in the intima, potentially facilitating lipid peroxidation; interestingly, it has been shown that the mural oxygen consumption increased significantly in experimental hypertension. 1214 Therefore, it has been suggested that free radical-induced endothelial injury may represent a critical step in a variety of cardiovascular diseases and that antioxidants may be able to protect endothelial cells against oxidative stress. Carvedilol (Fig 1) is a new antihypertensive agent with /3-adrenergic receptor blocking and vasodilating effects that is being marketed for the treatment of mild to moderate hypertension. 17 It is also being evaluated in clinical trials for use in chronic stable angina and congestive heart failure. 18 More recently, carvedilol has been shown to reduce infarct size in five different models of acute myocardial infarction in three different species. 18 The extraordinary cardiac protection of carvedilol has been explained in part by its antioxidant activity demonstrated in swine cardiac ventricular 19 and brain tissue homogenates. 20 The present study was carried out to explore whether carvedilol protects against oxidative injury in cultured bovine endothelial cells. The effects of carvedilol on oxygen radical-induced endothelial injury were compared with five commonly used /J-blockers and two other lipid-soluble antioxidants, probucol and nicardipine.
Methods

Materials
Carvedilol and celiprolol were from SmithKline Beecham, King of Prussia, Pa; propranolol, pindolol, atenolol, labetalol, probucol, glutathione (reduced GSH) and oxidized glutathione (GSSG), GSH reductase, /3-nicotinamide-adenine dinucleotide phosphate (/3-NADPH, reduced form), ADP, dihydroxyfumaric acid (DHF), butylated hydroxytoluene (BHT), 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB), catalase (EC 1.11.1.6, from bovine liver), 5-sulfosalicylic acid, and lactate dehydrogenase (LDH) reagent were from Sigma Chemical Co, St Louis, Mo; malonaldehyde bis(dimethyl acetal) (MDA), 2-methyl-2-nitrosopropane (MNP), and 2-vinylpyridine were from Aldrich Chemical Co, Milwaukee, Wis; nicardipine was from Syntex, Palo Alto, Calif; superoxide dismutase (SOD, from bovine erythrocyte) was from Calbiochem Corp, La Jolla, Calif; and Dulbecco's modified Eagle's medium (DMEM) was from GIBCO Laboratories, Grand Island, NY. All test drugs were dissolved in dimethyl sulfoxide and diluted with 0.9% NaCl. The final concentration of dimethyl sulfoxide was less than 1%.
Cell Culture
Bovine pulmonary artery endothelial cells were obtained from the American Type Culture Collection, Rockville, Md, and grown in DMEM supplemented with 15% heat-inactivated fetal calf serum in a humidified environment of 5% CO 2 and 95% air at 37°C. Cells were initially cultured in 150-cm 2 flasks and then subcultured into 24-well tissue culture plates for all the studies. Cells from passages 17 through 24 were used in this study.
Lipid Peroxidation Assay
The extent of lipid peroxidation was estimated as the formation of thiobarbituric acid-reactive substance (TBARS) as described previously. 20 Briefly, the medium in each well was removed and replaced with buffer (mmol/L: NaCl, 125; MgCl 2 , 1.2; KH 2 PO 4 , 10; glucose, 10; pH 7.2), and the cells were preincubated with the drug or vehicle for 20 minutes at 37°C. Oxygen radicals generated by DHF (1.7 mmol/L)/Fe 3+ -ADP (50 /xmol/L FeCl 3 and 0.5 mmol/L ADP) 21 were then added, and the incubation was continued for 2 hours unless otherwise indicated. At the end of the incubation, the supernatant of each dish was removed; butylated hydroxytoluene (BHT) and then the TBA reagent were added as described previously. 20 The TBARS was assayed on a fluorescence spectrophotometer (model 650-10S, Perkin-Elmer, Norwalk, Conn) with excitation at 520 nm and emission at 552 nm. The amounts of TBARS were expressed in equivalent MDA from a standard MDA curve prepared with MDA bis(dimethyl acetal). In a preliminary study it was found that the TBARS level in the supernatant was much higher than that in the cells (almost 10-fold), indicating that the lipid peroxidation product MDA dissolves in the supernatant. Therefore, only the supernatant was used for measurement of TBARS.
Measurement of Glutathione
Total and oxidized GSH levels were determined by the method of Tietze. 22 After oxidant injury as described above, the endothelial cell monolayer was washed twice with the buffer. Cells were then sonicated in the presence of 0.3 mL of 5-sulfosalicylic acid (5%) and centrifuged at 2000 rpm; the supernatant was used for measurement of GSH. For the assay of total GSH, 375 AIL of 0.3 mmol/L NADPH in 143 mmol/L sodium phosphate buffer with 6.3 mmol/L EDTA (pH 7.5), 50 fiL of 6 mmol/L DTNB, 50 fiL of sample, or standard was warmed to 30°C in a cuvette to which 50 ^iL of GSH reductase (0.5 U) was added. The change in optical density was measured at 412 nm and monitored continuously on a DU-6 spectrophotometer (Beckman Instruments, Irvine, Calif). The GSH content was quantitated by comparison with a standard curve generated with known amounts of GSH. Oxidized GSH (GSSG) was measured by the same method with prior masking of GSH with 2% (vol/vol) 2-vinylpyridine. 23 
Cytotoxicity Assay
Cellular injury was assessed by measuring the amount of LDH released from the cells into the medium. 24 Before the test drug was added, the medium in each well was replaced with prewarmed buffer as described above. The cells were incubated with drug or vehicle for 20 minutes at 37°C, and then the free radical-generating system (DHF/Fe 3+ -ADP) was added. At the end of incubation, 50 JAL of buffer from each well was removed, and LDH activity was determined by use of an LDH reagent (Sigma) following the manufacturer's instructions. Each LDH activity was compared with that released from cells after the addition of 0.1% Triton X-100 (total LDH release) and expressed as percent total release. Cellular viability was determined by estimation of the percentage of the total number of cells retaining fluorescein, as only alive cells can accumulate and retain the dye. 25 Briefly, at the end of incubation, the medium was aspirated, and fluorescein diacetate (10 fig in 1 mL of buffer per dish) was added. After 5 minutes of incubation, the staining solution was removed and replaced by 1 mL of buffer; the cells were examined immediately by fluorescence microscopy.
Spin-Trapping Experiments
The procedure for spin-trapping experiments was described previously by Mak et al. 26 Briefly, 40 mg MNP was dissolved in 10 mL of the incubation buffer at a slightly elevated temperature (35 C C). The spin trap stock solution was filtered to remove any solid residue before use. The endothelial cells (6xlO 6 cells per milliliter) were suspended in the buffer containing MNP, and carvedilol or vehicle was added and incubated at 37°C for 20 minutes. Oxygen free radicals were generated by addition of DHF/Fe 3+ -ADP, and incubation was continued at 37°C for 30 minutes. The radical spin adduct in the cell lipid was extracted by the Bligh-Dyer method. 27 The CHC1 3 phase was separated by centrifugation and evaporated to dryness under nitrogen gas. The lipid residue was redissolved in 60 /iL of CHCI3 and carefully transferred into a -ADP were added and incubation continued for 2 hours. LJpid peroxidation was estimated by the formation of thiobarbituric acid-reactive substance (TBARS) as described in "Methods." Each point is the mean±SEM of four to six independent experiments performed in duplicate or triplicate. Inset: Time course of DHF/Fe 3+ -ADP-initiated lipid peroxidation in endothelial cells. Cells were exposed to oxygen radicals for varying times before measurement of TBARS (n=3-6).
thin-wall glass capillary capped with parafilm to prevent the evaporation of the solvent. The sample was fitted into the TE im rectangular cavity for electron paramagnetic resonance (EPR) measurement in the X-band region. The EPR conditions were as follows: microwave frequency, 9.76 GHz; incident microwave power, 13.2 mW with 100 kHz field modulation of 2 G; and receiver gain, 4X10 5 . EPR spectra were obtained with an IBM (Bruker) ER200 series spectrometer interfaced to an IBM PC. The data acquisition system and software were obtained from Scientific Software Services, Bloomington, III.
Calculation of Drug Concentration Producing 50% Inhibition
The protective activity of the test compounds was calculated as percent inhibition of TBARS formation, GSH depletion, and LDH release from the cells obtained in the absence of the inhibitor (assumed to be 100%). Percent inhibition versus log concentration corresponding to 50% inhibition was expressed as the IQo value.
Statistics
Data in text and figures are mean±SEM unless otherwise stated. Statistical significance among groups was examined through one-way analysis of variance and Dunnett's multiple-range test. 28 Significant differences were accepted at a value of P<.05.
Results
Inhibition of Oxygen Radical-Initiated Lipid Peroxidation
The endothelial cells exposed to free radicals exhibited a time-dependent formation of TBARS (inset in Fig 2) . When the cells were exposed to oxygen radicals for 1, 1.5, or 2 hours, the formation of TBARS was 1.7±0.5,2.6±0.4, and 3.2±0.3 nmol per well equivalents of MDA (n=3-8), respectively, exceeding by 10-fold the levels found in the controls (without addition of oxygen radicals).
The ability of carvedilol and other ^blockers to inhibit lipid peroxidation in endothelial cells was tested as shown in Fig 2. Carvedilol dose-dependently inhibited oxygen radical-induced lipid peroxidation with an IC50 value of 2.6±0.7 junol/L (n=5). Propranolol inhibited TBARS formation with an IC*, value of 130±25 /xmol/L (n=4), whereas pindolol, labetalol, celiprolol, and atenolol had virtually no effect on oxygen radicalstimulated lipid peroxidation. Under the same conditions, the IQo values of nicardipine and probucol were 26.0±7.7 (n=4) and 0.9±0.3 /wnol/L (n=5), respectively. We have proved in a previous study that all the /3-blockers at the concentrations used had no interference with the TBARS assay. 
Protection of Oxygen Radical-Initiated Glutathione Depletion in Endothelial Cells
Oxygen radical stress resulted in a time-dependent depletion of endogenous total GSH in the endothelial cells (data not shown). GSH levels were significantly reduced after a 2-hour exposure of the cells to oxygen radicals, whereas GSH levels in the control endothelial cells remained unchanged (Table 1) . Carvedilol dosedependently prevented the oxygen radical-induced GSH loss in the endothelial cells (Table 1) with an IQo value of 1.8 /xmol/L. Significant protective effects on GSH depletion by propranolol and labetalol were evidenced only at the concentration of more than 100 /tmol/L. The levels of GSSG in the endothelial cells for all conditions were less than 5% of the total GSH (data not shown).
Protective Effects on Cellular Injury and Viability
The oxygen radicals caused a time-related LDH release from the endothelial cells, and carvedilol dosedependently prevented this damage with an IQo value of 4.2±0.7 /imol/L (n=7) as shown in Fig 3A. Propranolol, at 30 and 100 /xmol/L, reduced LDH release from the cells by 34.9±8.2% (P<.05) and 63.7±5.1% (P<.01) (n=5), respectively, whereas other /J-blockers, up to 100 p,mol/L, did not show any protective effect. Under the same conditions, the IQo values of nicardipine and probucol were 13.6±2.5 (n=5) and 1.0±0.2jtmol/L (n=4), respectively.
The protective effects of carvedilol on the viability of endothelial cells are shown in Fig 3B. The viable cell number did not change during a 2-hour period of incubation without oxygen radical challenge. However, when endothelial cells were exposed to oxygen radicals, the percent viable cell number was reduced time depen- -ADP was added and incubation continued for the time indicated. At the end of incubation (1, 1.5, or 2 hours), an aliquot of supernatant was taken for LDH assay; fluorescein diacetate retention was used as an index of viability (see "Methods"). LDH released from cells treated with 0.1% Triton X-100 was assumed as total LDH release. Each point is the mean±SEM of five independent experiments performed in duplicate or triplicate. dently (control). Carvedilol provided significant cytoprotection against free radical-induced cell death. The EQo value (50% cell survival after a 2-hour exposure to oxygen radicals) of carvedilol was 3.2±0.6 jtmol/L. Propranolol, at 30 and 100 p,mol/L, increased cell survival from 8.3±1.7% (control) to 17.5±1.2% (P<.05) and 44.5±2.1% (/><.O1) (n=5), respectively, whereas the other /3-blockers had no protective effect. Under the same conditions, the EQo values of nicardipine and probucol were 16.9±4.9 and 0.9±0.3 limolfL, respectively.
The protective effects of SOD and catalase against oxygen radical-induced cell damage were also tested. SOD, at 100 U/mL, and catalase, at 600 U/mL, reduced LDH release by 43.37±2.45% and 60.51 ±4.05% and cell death from 91 ±3% (control) to 64±7% and 40±2% (n=3), respectively.
Because the acute effect of carvedilol may not represent the effect associated with chronic dosing of the drug, the effect of the duration of pretreatment with carvedilol on oxygen radical-initiated LDH release and endothelial cell death was also investigated. As shown in Table 2 , the IQo value for inhibition of LDH release and the EQo value for protection of cell survival from free radical stress reduced when preincubation time with carvedilol increased. Carvedilol at the test concentrations had no effect on cell growth during a 7-day period. The cell numbers and viability between vehicle-and carvedilol-treated cells were not different (Fig 4, A and D) . The protective effect of propranolol against oxidative injury in the endothelial cells was also enhanced by increasing the duration of cell Table 2 . Cells were stained with fluorescein dlacetate as described in "Methods." (Magnification x150.) pretreatment with the drug. The LDH release was reduced from 58.7±3.2% (control) to 38.1±5.4% (P<.05), 29.4±4.8% (i><.01), and 22.9±3.1% (P<.01) (n=4), and the cell survival increased from 5.5±2.5% (control) to 15.4±4.5%, 37.5±4.2% (P< .01), and 69.1±3.4% (P<.0l) (n=4) when the cells were treated with 30 fimo\/L propranolol for 20 minutes 3 and 7 days before oxygen radical challenge, respectively. However, under the same conditions, the effect of atenolol (30 fimolfL) was not significant (data not shown). It was also found that both propranolol and atenolol above 30 /xmol/L showed cytotoxicity when incubation was longer than 1 day.
Scavenging Free Radical in Cell Lipid
Fig 5 shows representative EPR spectra of MNPradical adducts extracted from the cell lipid fraction. The nitrogen hyperfine coupling constants (ranging from 15.9 to 16.3 G) are consistent with those observed for MNP adducts derived from lipid radicals. 2629 -31 Although the identity of the spin-trapped radicals cannot be determined from the EPR spectra alone, the EPR signal is clearly related to the iron-dependent oxygen radical formations. In the absence of DHF/Fe 3+ -ADP, the lipid extract of endothelial cells showed negligible spin-adduct formation. The magnitude of the EPR signals was reduced by 32.9±11.2% (n=3) and 62.7±71.8% (n=2), when the cells were pretreated with carvedilol at 1 and 10 /umol/L, respectively.
Discussion
The DHF/Fe 3+ -ADP system is widely used for initiating lipid peroxidation, and its main oxygen free radical has been confirmed as a hydroxyl radical (OH • ). 1S -32 MDA formation assayed by the TBA method was used as an index of membrane lipid peroxidation because of its sensitivity and simplicity. However, the specificity of the TBA method must be considered. 33 To minimize the artifacts, we used only the supernatant that contains water-soluble lipid peroxidation product-MDA from the cells for the TBARS assay. Moreover, the chainbreaking antioxidant BHT was added before the TBA reagents were added. 34 The TBARS level in control samples (cells without an oxygen radical-generating system) was almost undetectable. To further validate our observation, we used the depletion of intracellular GSH-one of the major intracellular antioxidant defense systems in the endothelial cell for detoxifying lipid peroxides 3536 -as another index of oxidative stress. The addition of oxygen radicals to the endothelial cells resulted in a significant increase of TBARS formation and depletion of GSH in a time-dependent manner. Meanwhile, cell injury, as evidenced by LDH release, and cell death increased in a similar time-related manner. Carvedilol showed a remarkable inhibition of oxygen radicalinitiated lipid peroxidation in endothelial cells. Oxygen radical-induced GSH depletion, cell damage, and cell death were also prevented by carvedilol with a potency similar to that for inhibition of lipid peroxidation. Under the same conditions, other /J-blockers showed a significantly lesser or no effect for both inhibition of lipid peroxidation and cell protection. Nicardipine was also effective in inhibition of lipid peroxidation, in accordance with the results reported by Mak and coworkers, 15 but was significantly less potent than carvedilol. As expected, both SOD and catalase showed a partial protection against cell damage induced by free radicals, because scavenging O 2õ r H 2 O 2 reduces the production of OH • M in this system. The order of potency for inhibition of lipid peroxidation was positively correlated with the order of potency for prevention of cell injury and death among carvedilol, nicardipine, and probucol, suggesting that cell damage (LDH release) and loss of viability were secondary to the primary event of lipid peroxidation. However, it has been shown that oxidative stress can also damage other vital cellular structures such as proteins and DNA and produce interrelated derangements of cell metabolism leading to damage of membrane receptors and changes in intracellular homeostasis (for review, see Reference 33) . Oxygen radical-induced damage to all these sites may have contributed to the oxidative injuries of endothelial cells and could be protected by carvedilol via its antioxidant activity. For other /3-blockers, especially propranolol, there was a difference in the extent of the protection between TBARS formation and cell damage or cell death. In the presence of 30 and 100 ^unol/L propranolol, there was only a small degree of reduction in oxygen radical-initiated TBARS formation (Fig 2) , in accordance with the finding that propranolol possesses minimal scavenging ability, 37 -38 whereas the LDH release and cell death were significantly reduced. The difference in the extent of the protection between TBARS formation and cell damage afforded by propranolol may indicate the possibility of the existence of other mechanisms for cell protection. It has been suggested that propranolol may interact with membrane lipids and therefore interrupt the free radical chain reactions, 26 which is an activity also shared by the calcium blockers. 15 It was also shown that propranolol possesses membrane-stabilizing and local anesthetic properties that may provide some protective effect on cells. 26 The scavenging ability of carvedilol in the aqueous phase has been observed previously. 20 The present study further demonstrated that the formation of irondependent lipid radicals in endothelial cells was also inhibited by carvedilol. Previous studies have shown that lipid-derived radicals in liposomes, 29 lipoprotein lipids, 30 and cell membranes 31 were readily trapped by the lipophilic spin-trap MNP to form stable adducts of well-defined EPR spectra. Our EPR signals are consistent with those reported in the literature and therefore are most likely to result from the trapping of lipidderived radicals. Carvedilol may suppress the formation of lipid radicals via two mechanisms: (1) by scavenging oxygen radicals in aqueous phase, therefore preventing oxygen radical-initiated lipid peroxidation and reducing formation of lipid radicals, and (2) by scavenging lipid radicals directly, thus breaking the chain reaction in membranes. Although the present data do not allow us to differentiate between these two mechanisms, the most important conclusion is that carvedilol indeed inhibits lipid radical formation.
The effective concentrations of carvedilol for inhibition of lipid peroxidation and protection against oxidative injury in endothelial cells appeared to be approximately 1 /imol/L when the cells were pretreated with the drug for 20 minutes before the addition of oxygen free radicals. The plasma peak concentration of carvedilol in human volunteers has been reported to be 0.3 ^jnol/L after a single oral dose of 50 mg. 39 Therefore, the clinical relevance of the antioxidant effect of carvedilol is quite apparent. Carvedilol is a highly lipophilic compound with a partition coefficient value of 3.4 (log[octanol/H 2 O], unpublished data), higher than that of propranolol (3.O). 40 It has been reported that accumulation of propranolol in Purkinje fibers and platelets reached concentrations up to 30-to 40-fold higher than plasma concentrations. 41 ' 42 It was also reported that hydrophobic calcium blockers reside in membranes at concentrations two orders of magnitude higher than in the aqueous phase. 43 The large distribution volume of carvedilol in humans (132 L) indicates that carvedilol is extensively distributed to the tissue. 44 As shown in Table 2 , increasing the duration of cell pretreatment with carvedilol significantly increased the potency of the drug for protection against oxygen stress. The IQo values for protecting cell injury (LDH release) and the EC50 values for protecting cell death were significantly reduced when compared with a 20-minute pretreatment. Similarly, the protective effect of propranolol was also found to be enhanced when the preincubation time was increased. In fact, the concentrations of carvedilol found to protect endothelial cells from oxygen radical-induced death after chronic treatment were well within the concentrations found in the blood after oral administration to humans. In a recent in vitro study it was reported that the concentrations of probucol in the cells increased approximately sixfold during a 24-hour period of incubation. 16 Although we do not know the exact levels of carvedilol in cell membranes, it is conceivable that an effective level of the drug may be attainable in vivo.
In conclusion, our results suggest that carvedilol protects endothelial cells against oxygen radical-induced cell injury and death. The mechanism of this protective effect is due to its ability to scavenge free radicals. In view of increasing evidence that oxygen radical-related endothelial injury may promote atherogenesis, we speculate that endothelial cytoprotection conferred by the antioxidant activity of carvedilol would increase its therapeutic value as an antihypertensive agent.
